The 21,000-square-foot new building, at 5490 Cobbler Way, replaces the cancer practice’s longtime western suburban facility ...

Advances in treatment and new drugs are pushing cancer care even farther away from hospital campuses into outpatient settings ...

Joseph Alvarnas, MD, of City of Hope, recaps yesterday's Institute for Value-Based Medicine® (IVBM) event on value-based oncology care, emphasizing patient-centered approaches and how attendees can ...

Medical oncologist and hematologist Dr. Cherie Tan has joined Hematology-Oncology Associates of CNY and will work in the new Camillus Cancer Center. >> Send us your company’s news about People in ...

Zoetis, announced it will introduce a new diagnostic tool Vetscan OptiCell, a hematology analyzer that is cartridge-based and ...

NATIONAL GRANDPARENTS DAY | WORLD AMPERSAND DAY | NATIONAL HUG YOUR HOUND DAY | NATIONAL PEDIATRIC HEMATOLOGY/ONCOLOGY NURSES ...

While infections pose a risk for morbidity and mortality among patients with MDS, more needs to be studied about the topic, ...

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in ...

Did you know that the COVID-19 mRNA vaccination is safe and beneficial for children and adults with sickle cell disease?

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

The new executive director of New York Oncology Hematology is Allyson Letendre Petrone, the physician group announced Monday.

Based on an Avalere Health report, Community Oncology Alliance warns that IRA negotiations could slice down payments needed ...